Edition:
United States

Biohaven Pharmaceutical Holding Company Ltd (BHVN.N)

BHVN.N on New York Stock Exchange

32.42USD
20 Nov 2018
Change (% chg)

$-0.34 (-1.04%)
Prev Close
$32.76
Open
$32.07
Day's High
$34.07
Day's Low
$31.79
Volume
61,348
Avg. Vol
80,318
52-wk High
$44.26
52-wk Low
$16.51

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Declan Doogan

66 Independent Chairman of the Board

Vlad Coric

47 2015 Chief Executive Officer, Director

James Engelhart

54 2016 Chief Financial Officer

Charles Conway

56 2017 Chief Scientific Officer

Kimberly Gentile

52 2014 Vice President - Clinical Operations